1. Home
  2. VCYT vs RHI Comparison

VCYT vs RHI Comparison

Compare VCYT & RHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VCYT
  • RHI
  • Stock Information
  • Founded
  • VCYT 2006
  • RHI 1948
  • Country
  • VCYT United States
  • RHI United States
  • Employees
  • VCYT N/A
  • RHI N/A
  • Industry
  • VCYT Medical Specialities
  • RHI Professional Services
  • Sector
  • VCYT Health Care
  • RHI Consumer Discretionary
  • Exchange
  • VCYT Nasdaq
  • RHI Nasdaq
  • Market Cap
  • VCYT 2.8B
  • RHI 3.3B
  • IPO Year
  • VCYT 2013
  • RHI N/A
  • Fundamental
  • Price
  • VCYT $36.80
  • RHI $29.01
  • Analyst Decision
  • VCYT Buy
  • RHI Sell
  • Analyst Count
  • VCYT 10
  • RHI 7
  • Target Price
  • VCYT $40.40
  • RHI $40.00
  • AVG Volume (30 Days)
  • VCYT 788.0K
  • RHI 2.0M
  • Earning Date
  • VCYT 11-04-2025
  • RHI 10-22-2025
  • Dividend Yield
  • VCYT N/A
  • RHI 8.12%
  • EPS Growth
  • VCYT N/A
  • RHI N/A
  • EPS
  • VCYT 0.34
  • RHI 1.54
  • Revenue
  • VCYT $479,129,000.00
  • RHI $5,458,499,000.00
  • Revenue This Year
  • VCYT $14.48
  • RHI N/A
  • Revenue Next Year
  • VCYT $9.79
  • RHI $3.32
  • P/E Ratio
  • VCYT $109.69
  • RHI $18.86
  • Revenue Growth
  • VCYT 19.91
  • RHI N/A
  • 52 Week Low
  • VCYT $22.61
  • RHI $26.99
  • 52 Week High
  • VCYT $47.32
  • RHI $78.41
  • Technical
  • Relative Strength Index (RSI)
  • VCYT 62.00
  • RHI 26.13
  • Support Level
  • VCYT $34.38
  • RHI $26.99
  • Resistance Level
  • VCYT $37.07
  • RHI $32.90
  • Average True Range (ATR)
  • VCYT 1.23
  • RHI 1.24
  • MACD
  • VCYT -0.06
  • RHI -0.30
  • Stochastic Oscillator
  • VCYT 90.96
  • RHI 26.50

About VCYT Veracyte Inc.

Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder). In addition, its Percepta Nasal Swab test is being run in CLIA labs in support of clinical studies.

About RHI Robert Half Inc.

Robert Half Inc was founded in 1948, Robert Half provides temporary, permanent, and outcome-based staffing for both in-person and remote positions in the finance and accounting, technology, legal, marketing, and administrative fields. Its subsidiary consulting arm, Protiviti, specializes in technology, risk, auditing, and compliance matters. The firm generates its sales inside the U.S. and is one of the specialized firms in the fragmented U.S. staffing industry. The firm generates annual revenue of around $7 billion.

Share on Social Networks: